Estrella Immunopharma, Inc.ESLANASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank40
Studio
Year-over-Year Change

Free cash flow yield

Latest
-3.11%
↑ 72% vs avg
Percentile
P40
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-11.06%
Historical baseline
PeriodValueYoY Change
2025-3.11%+82.1%
2024-17.36%+58.2%
2023-41.50%-2257.4%
2022-1.76%+28.6%
2021-2.47%-1161.2%
2020-0.20%-